Latest MUC1 Stories
SEATTLE, June 2, 2014 /PRNewswire/ - Oncothyreon Inc.
SEATTLE, WA and HAMPTON, NJ, May 29, 2014 /PRNewswire/ - Oncothyreon Inc. (NASDAQ: ONTY) and Celldex Therapeutics, Inc., (NASDAQ: CLDX) today announced that they have agreed to collaborate on
Researchers at UC Davis have found that the investigational cancer vaccine tecemotide, when administered with the chemotherapeutic cisplatin, boosted immune response and reduced the number of
Australian scientists believe they may have found a new way to gauge the prognosis for people with peritoneal mesothelioma.
ALISO VIEJO, Calif. and WALTHAM, Mass., Nov. 30 /PRNewswire-FirstCall/ -- Clarient, Inc.
A special protein in the lining of the stomach has been shown to be an important part of the bodyâ€™s defense against the stomach ulcer bacterium Helicobacter pylori in a new study from the Sahlgrenska Academy. The discovery may explain why the bacterium makes some people more ill than others.
By Albrecht, H Denardo, G L; Denardo, S J Pretargeted radioimmunotherapy (RIT) is a promising approach to increase the therapeutic index of RIT for malignant solid tumors.
- A transitional zone between two communities containing the characteristic species of each.